Literature DB >> 7980542

The metabolic pathway generating p3, an A beta-peptide fragment, is probably non-amyloidogenic.

J Näslund1, M Jensen, L O Tjernberg, J Thyberg, L Terenius, C Nordstedt.   

Abstract

The Alzheimer a beta amyloid precursor protein is metabolized by at least two secretory pathways. One generates the A beta peptide and the other a N-terminally truncated A beta fragment termed p3 that is considered non-amyloidogenic. However, direct evidence is missing. We have undertaken to synthesize and purify p3. Pure p3 polymerizes in vitro, forming a lattice with an ultrastructure distinct from the linear fibrils of A beta. In contrast to amyloid, polymerized p3 does not bind thioflavine T. It is therefore concluded that amino acids in the N-terminal part of the A beta molecule are required for formation of typical amyloid fibrils and that the metabolic pathway generating p3 probably is non-amyloidogenic

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980542     DOI: 10.1006/bbrc.1994.2527

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.

Authors:  Zhiyou Cai; Zhou Liu; Ming Xiao; Chuanling Wang; Fuming Tian
Journal:  Neurochem Res       Date:  2017-08-24       Impact factor: 3.996

2.  Effects of N-Terminal Residues on the Assembly of Constrained β-Hairpin Peptides Derived from Aβ.

Authors:  Tuan D Samdin; Michał Wierzbicki; Adam G Kreutzer; William J Howitz; Mike Valenzuela; Alberto Smith; Victoria Sahrai; Nicholas L Truex; Matthew Klun; James S Nowick
Journal:  J Am Chem Soc       Date:  2020-06-22       Impact factor: 15.419

Review 3.  Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.

Authors:  Gouri Chopra; Shabnam Shabir; Sumaira Yousuf; Simran Kauts; Shahnawaz A Bhat; Ashiq H Mir; Mahendra P Singh
Journal:  Mol Neurobiol       Date:  2022-10-07       Impact factor: 5.682

4.  A robust preparation method for the amyloidogenic and intrinsically disordered amyloid-α peptide.

Authors:  Ariel J Kuhn; Jevgenij A Raskatov
Journal:  J Pept Sci       Date:  2022-05-06       Impact factor: 2.408

Review 5.  Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1.

Authors:  Ariel J Kuhn; Jevgenij Raskatov
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  Alzheimer's Disease "Non-amyloidogenic" p3 Peptide Revisited: A Case for Amyloid-α.

Authors:  Ariel J Kuhn; Benjamin S Abrams; Stella Knowlton; Jevgenij A Raskatov
Journal:  ACS Chem Neurosci       Date:  2020-05-22       Impact factor: 4.418

Review 7.  O-GlcNAcylation and neurodegeneration.

Authors:  Willayat Y Wani; John C Chatham; Victor Darley-Usmar; Lori L McMahon; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2016-08-04       Impact factor: 4.077

8.  Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence.

Authors:  B De Strooper; M Simons; G Multhaup; F Van Leuven; K Beyreuther; C G Dotti
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

Review 9.  Activation of mTOR: a culprit of Alzheimer's disease?

Authors:  Zhiyou Cai; Guanghui Chen; Wenbo He; Ming Xiao; Liang-Jun Yan
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-09       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.